Gain Therapeutics Inc (GANX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GANX? Forum Prognose

Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.1153	-	0.106	0.1299	0.0552
Operating Expenses	0.67% 4.3777	4.4072	4.885	7.7311	5.285
Benefits Costs and Expenses	12.74% 4.1096	4.7095	4.8028	7.7913	5.1758
Costs And Expenses	12.74% 4.1096	4.7095	4.8028	7.7913	5.1758
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	0.67% -4.3777	-4.4072	-4.885	-7.7311	-5.2298
Net Interest Income/Expense	8.50% 0.1153	0.1063	0.106	0.1299	0.152
Interest Income/Expense After Provision For Losses	8.50% 0.1153	0.1063	0.106	0.1299	0.152
Income/Loss From Continuing Operations Before Tax	15.19% -3.9943	-4.7095	-4.6968	-7.6614	-5.1206
Income Tax Expense/Benefit	37.04% 0.0199	0.0145	0.0215	0.0266	0.0167
Income/Loss From Continuing Operations After Tax	15.02% -4.0142	-4.724	-4.7183	-7.688	-5.1373
Net Income/Loss	15.02% -4.0142	-4.724	-4.7183	-7.688	-5.1373
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,586% 17.98	0.6693	12.70	12.39	11.94
Diluted Average Shares	2,586% 17.98	0.6693	12.70	12.39	11.94
Basic Earnings Per Share	24.14% -0.22	-0.29	-0.37	-0.62	-0.43
Diluted Earnings Per Share	24.14% -0.22	-0.29	-0.37	-0.62	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%